IMDRF is a voluntary group of medical device regulators that work together to harmonize medical device regulation globally, building on the foundation of the Global Harmonization Task Force (GHTF). Members include regulators from Australia, Brazil, Canada, China, the EU, Japan, Russia, Singapore, South Korea, the UK and the US, with the WHO as an official observer. It succeeded GHTF in 2011. Its documents on Software as a Medical Device, MDSAP, adverse event terminology and cybersecurity are widely referenced in national rules and guidance.

Why it matters

Many widely adopted concepts - SaMD risk categorization, MDSAP, UDI principles - originated in IMDRF working groups.

Common pitfalls

•A common pitfall is misunderstanding IMDRF documents as legally binding regulations rather than voluntary guidance.
•Another mistake is assuming immediate, universal adoption of all IMDRF guidance by every national regulator.
•Failing to recognize that IMDRF contributions often form the basis for later national or regional regulatory frameworks can lead to a lack of proactive planning.

Sources

IMDRF · IMDRF
FDA - Medical Devices · FDA
European Commission - Medical Devices · European Commission

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.